Effect of Biological Disease-modifying Anti-rheumatic Drugs on Airway and Interstitial Lung Disease in Patients with Rheumatoid Arthritis

OBJECTIVE: Biological disease-modifying anti-rheumatic drugs (bDMARDs) represent an important advance in alleviating rheumatoid arthritis (RA), but their effect on rheumatic airway disease (AD) and interstitial lung disease (ILD) is still unclear. This study was performed to evaluate the association...

Descripción completa

Detalles Bibliográficos
Autores principales: Kurata, Izumi, Tsuboi, Hiroto, Terasaki, Mayu, Shimizu, Masaru, Toko, Hirofumi, Honda, Fumika, Ohyama, Ayako, Yagishita, Mizuki, Osada, Atsumu, Ebe, Hiroshi, Kawaguchi, Hoshimi, Takahashi, Hiroyuki, Hagiwara, Shinya, Asashima, Hiromitsu, Kondo, Yuya, Matsumoto, Isao, Sumida, Takayuki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Japanese Society of Internal Medicine 2019
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6630137/
https://www.ncbi.nlm.nih.gov/pubmed/30799358
http://dx.doi.org/10.2169/internalmedicine.2226-18

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6630137/
https://www.ncbi.nlm.nih.gov/pubmed/30799358
http://dx.doi.org/10.2169/internalmedicine.2226-18

Ejemplares similares